{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:31:01Z","timestamp":1785184261898,"version":"3.55.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11684-021-0911-0","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T08:02:31Z","timestamp":1661241751000},"page":"784-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Palmitoylation of GNAQ\/11 is critical for tumor cell proliferation and survival in GNAQ\/11-mutant uveal melanoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhou","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruibao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"issue":"1","key":"911_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","volume":"170","author":"DK Simanshu","year":"2017","unstructured":"Simanshu DK, Nissley DV, McCormick F. RAS proteins and their regulators in human disease. Cell 2017; 170(1): 17\u201333","journal-title":"Cell"},{"issue":"2","key":"911_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrc2069","volume":"7","author":"RT Dorsam","year":"2007","unstructured":"Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007; 7(2): 79\u201394","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"911_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrc3521","volume":"13","author":"M O\u2019Hayre","year":"2013","unstructured":"O\u2019Hayre M, V\u00e1zquez-Prado J, Kufareva I, Stawiski EW, Handel TM, Seshagiri S, Gutkind JS. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 2013; 13(6): 412\u2013424","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"911_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, Carvajal RD, Belfort RN, Jia R, Shields JA, Damato BE. Uveal melanoma. Nat Rev Dis Primers 2020; 6(1): 24","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"911_CR5","first-page":"1230","volume":"6","author":"P Jovanovic","year":"2013","unstructured":"Jovanovic P, Mihajlovic M, Djordjevic-Jocic J, Vlajkovic S, Cekic S, Stefanovic V. Ocular melanoma: an overview of the current status. Int J Clin Exp Pathol 2013; 6(7): 1230\u20131244","journal-title":"Int J Clin Exp Pathol"},{"issue":"33","key":"911_CR6","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1200\/JCO.20.00198","volume":"38","author":"R Seth","year":"2020","unstructured":"Seth R, Messersmith H, Kaur V, Kirkwood JM, Kudchadkar R, McQuade JL, Provenzano A, Swami U, Weber J, Alluri KC, Agarwala S, Ascierto PA, Atkins MB, Davis N, Ernstoff MS, Faries MB, Gold JS, Guild S, Gyorki DE, Khushalani NI, Meyers MO, Robert C, Santinami M, Sehdev A, Sondak VK, Spurrier G, Tsai KK, van Akkooi A, Funchain P. Systemic therapy for melanoma: ASCO Guideline. J Clin Oncol 2020; 38(33): 3947\u20133970","journal-title":"J Clin Oncol"},{"issue":"5","key":"911_CR7","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.cell.2018.03.018","volume":"173","author":"Q Hu","year":"2018","unstructured":"Hu Q, Shokat KM. Disease-causing mutations in the G protein G\u03b1s subvert the roles of GDP and GTP. Cell 2018; 173(5): 1254\u20131264.e11","journal-title":"Cell"},{"issue":"5","key":"911_CR8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2017.04.002","volume":"31","author":"X Chen","year":"2017","unstructured":"Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H, Coupland SE, Roose JP, Bastian BC. RasGRP3 mediates MAPK pathway activation in GNAQ mutant uveal melanoma. Cancer Cell 2017; 31(5): 685\u2013696.e6","journal-title":"Cancer Cell"},{"issue":"23","key":"911_CR9","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O\u2019Brien J, Bastian BC. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010; 363(23): 2191\u20132199","journal-title":"N Engl J Med"},{"issue":"3","key":"911_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ccell.2019.01.009","volume":"35","author":"X Feng","year":"2019","unstructured":"Feng X, Arang N, Rigiracciolo DC, Lee JS, Yeerna H, Wang Z, Lubrano S, Kishore A, Pachter JA, K\u00f6nig GM, Maggiolini M, Kostenis E, Schlaepfer DD, Tamayo P, Chen Q, Ruppin E, Gutkind JS. A platform of synthetic lethal gene interaction networks reveals that the GNAQ uveal melanoma oncogene controls the Hippo pathway through FAK. Cancer Cell 2019; 35(3): 457\u2013472.e5","journal-title":"Cancer Cell"},{"issue":"6","key":"911_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","volume":"25","author":"X Feng","year":"2014","unstructured":"Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, Zaidi MR, Ksander BR, Merlino G, Sodhi A, Chen Q, Gutkind JS. Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell 2014; 25(6): 831\u2013845","journal-title":"Cancer Cell"},{"issue":"6","key":"911_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2014.04.017","volume":"25","author":"FX Yu","year":"2014","unstructured":"Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, Zhao L, Peyman G, Ouyang H, Jiang W, Zhao J, Chen X, Zhang L, Wang CY, Bastian BC, Zhang K, Guan KL. Mutant Gq\/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell 2014; 25(6): 822\u2013830","journal-title":"Cancer Cell"},{"issue":"6","key":"911_CR13","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/bjc.2017.259","volume":"117","author":"MJC Vader","year":"2017","unstructured":"Vader MJC, Madigan MC, Versluis M, Suleiman HM, Gezgin G, Gruis NA, Out-Luiting JJ, Bergman W, Verdijk RM, Jager MJ, van der Velden PA. GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi. Br J Cancer 2017; 117(6): 884\u2013887","journal-title":"Br J Cancer"},{"issue":"5","key":"911_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1158\/1541-7786.MCR-17-0007","volume":"15","author":"V Chua","year":"2017","unstructured":"Chua V, Lapadula D, Randolph C, Benovic JL, Wedegaertner PB, Aplin AE. Dysregulated GPCR signaling and therapeutic options in uveal melanoma. Mol Cancer Res 2017; 15(5): 501\u2013506","journal-title":"Mol Cancer Res"},{"key":"911_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejca.2018.08.005","volume":"103","author":"T Steeb","year":"2018","unstructured":"Steeb T, Wessely A, Ruzicka T, Heppt MV, Berking C. How to MEK the best of uveal melanoma: a systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma. Eur J Cancer 2018; 103: 41\u201351","journal-title":"Eur J Cancer"},{"issue":"573","key":"911_CR16","doi-asserted-by":"publisher","first-page":"eaau5948","DOI":"10.1126\/scisignal.aau5948","volume":"12","author":"S Annala","year":"2019","unstructured":"Annala S, Feng X, Shridhar N, Eryilmaz F, Patt J, Yang J, Pfeil EM, Cervantes-Villagrana RD, Inoue A, H\u00e4berlein F, Slodczyk T, Reher R, Kehraus S, Monteleone S, Schrage R, Heycke N, Rick U, Engel S, Pfeifer A, Kolb P, K\u00f6nig G, B\u00fcnemann M, T\u00fcting T, V\u00e1zquez-Prado J, Gutkind JS, Gaffal E, Kostenis E. Direct targeting of G\u03b1q and G\u03b111 oncoproteins in cancer cells. Sci Signal 2019; 12(573): eaau5948","journal-title":"Sci Signal"},{"issue":"9","key":"911_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2011; 118(9): 1881\u20131885","journal-title":"Ophthalmology"},{"issue":"4","key":"911_CR18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ajo.2003.11.059","volume":"137","author":"JJ Arnold","year":"2004","unstructured":"Arnold JJ, Blinder KJ, Bressler NM, Bressler SB, Burdan A, Haynes L, Lim JI, Miller JW, Potter MJ, Reaves A, Rosenfeld PJ, Sickenberg M, Slakter JS, Soubrane G, Strong HA, Stur M; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Acute severe visual acuity decrease after photodynamic therapy with verteporfin: case reports from randomized clinical trials\u2014TAP and VIP report no. 3. Am J Ophthalmol 2004; 137(4): 683\u2013696","journal-title":"Am J Ophthalmol"},{"issue":"16","key":"911_CR19","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1158\/1078-0432.CCR-11-3227","volume":"18","author":"JS Khalili","year":"2012","unstructured":"Khalili JS, Yu X, Wang J, Hayes BC, Davies MA, Lizee G, Esmaeli B, Woodman SE. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res 2012; 18(16): 4345\u20134355","journal-title":"Clin Cancer Res"},{"issue":"39","key":"911_CR20","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1038\/onc.2013.418","volume":"33","author":"X Chen","year":"2014","unstructured":"Chen X, Wu Q, Tan L, Porter D, Jager MJ, Emery C, Bastian BC. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. Oncogene 2014; 33(39): 4724\u20134734","journal-title":"Oncogene"},{"issue":"11","key":"911_CR21","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1158\/1078-0432.CCR-20-3363","volume":"27","author":"JS Paradis","year":"2021","unstructured":"Paradis JS, Acosta M, Saddawi-Konefka R, Kishore A, Gomes F, Arang N, Tiago M, Coma S, Lubrano S, Wu X, Ford K, Day CP, Merlino G, Mali P, Pachter JA, Sato T, Aplin AE, Gutkind JS. Synthetic lethal screens reveal cotargeting FAK and MEK as a multimodal precision therapy for GNAQ-driven uveal melanoma. Clin Cancer Res 2021; 27(11): 3190\u20133200","journal-title":"Clin Cancer Res"},{"issue":"39","key":"911_CR22","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1038\/onc.2013.555","volume":"33","author":"MS Sagoo","year":"2014","unstructured":"Sagoo MS, Harbour JW, Stebbing J, Bowcock AM. Combined PKC and MEK inhibition for treating metastatic uveal melanoma. Oncogene 2014; 33(39): 4722\u20134723","journal-title":"Oncogene"},{"issue":"46","key":"911_CR23","doi-asserted-by":"publisher","first-page":"47438","DOI":"10.1074\/jbc.M408846200","volume":"279","author":"J Takasaki","year":"2004","unstructured":"Takasaki J, Saito T, Taniguchi M, Kawasaki T, Moritani Y, Hayashi K, Kobori M. A novel G\u03b1q\/11-selective inhibitor. J Biol Chem 2004; 279(46): 47438\u201347445","journal-title":"J Biol Chem"},{"issue":"31","key":"911_CR24","doi-asserted-by":"publisher","first-page":"13666","DOI":"10.1073\/pnas.1003553107","volume":"107","author":"A Nishimura","year":"2010","unstructured":"Nishimura A, Kitano K, Takasaki J, Taniguchi M, Mizuno N, Tago K, Hakoshima T, Itoh H. Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule. Proc Natl Acad Sci USA 2010; 107(31): 13666\u201313671","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"911_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11418-012-0644-0","volume":"67","author":"K Zaima","year":"2013","unstructured":"Zaima K, Deguchi J, Matsuno Y, Kaneda T, Hirasawa Y, Morita H. Vasorelaxant effect of FR900359 from Ardisia crenata on rat aortic artery. J Nat Med 2013; 67(1): 196\u2013201","journal-title":"J Nat Med"},{"issue":"1","key":"911_CR26","doi-asserted-by":"publisher","first-page":"10156","DOI":"10.1038\/ncomms10156","volume":"6","author":"R Schrage","year":"2015","unstructured":"Schrage R, Schmitz AL, Gaffal E, Annala S, Kehraus S, Wenzel D, B\u00fcllesbach KM, Bald T, Inoue A, Shinjo Y, Galandrin S, Shridhar N, Hesse M, Grundmann M, Merten N, Charpentier TH, Martz M, Butcher AJ, Slodczyk T, Armando S, Effern M, Namkung Y, Jenkins L, Horn V, St\u00f6\u00dfel A, Dargatz H, Tietze D, Imhof D, Gal\u00e9s C, Drewke C, M\u00fcller CE, H\u00f6lzel M, Milligan G, Tobin AB, Gomeza J, Dohlman HG, Sondek J, Harden TK, Bouvier M, Laporte SA, Aoki J, Fleischmann BK, Mohr K, K\u00f6nig GM, T\u00fcting T, Kostenis E. The experimental power of FR900359 to study Gq-regulated biological processes. Nat Commun 2015; 6(1): 10156","journal-title":"Nat Commun"},{"key":"911_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrm3255","volume":"13","author":"IM Ahearn","year":"2012","unstructured":"Ahearn IM, Haigis K, Bar-Sagi D, Philips MR. Regulating the regulator: post-translational modification of RAS. Nat Rev Mol Cell Biol 2012; 13: 39\u201351","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"8","key":"911_CR28","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1073\/pnas.90.8.3675","volume":"90","author":"ME Linder","year":"1993","unstructured":"Linder ME, Middleton P, Hepler JR, Taussig R, Gilman AG, Mumby SM. Lipid modifications of G proteins: alpha subunits are palmitoylated. Proc Natl Acad Sci USA 1993; 90(8): 3675\u20133679","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"911_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejcb.2018.03.005","volume":"97","author":"I De","year":"2018","unstructured":"De I, Sadhukhan S. Emerging roles of DHHC-mediated protein S-palmitoylation in physiological and pathophysiological context. Eur J Cell Biol 2018; 97(5): 319\u2013338","journal-title":"Eur J Cell Biol"},{"issue":"5","key":"911_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2011.01.003","volume":"36","author":"J Greaves","year":"2011","unstructured":"Greaves J, Chamberlain LH. DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem Sci 2011; 36(5): 245\u2013253","journal-title":"Trends Biochem Sci"},{"issue":"17","key":"911_CR31","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1182\/blood-2009-03-213876","volume":"115","author":"B Cuiffo","year":"2010","unstructured":"Cuiffo B, Ren R. Palmitoylation of oncogenic NRAS is essential for leukemogenesis. Blood 2010; 115(17): 3598\u20133605","journal-title":"Blood"},{"issue":"5","key":"911_CR32","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/leu.2015.293","volume":"30","author":"P Liu","year":"2016","unstructured":"Liu P, Jiao B, Zhang R, Zhao H, Zhang C, Wu M, Li D, Zhao X, Qiu Q, Li J, Ren R. Palmitoylacyltransferase Zdhhc9 inactivation mitigates leukemogenic potential of oncogenic Nras. Leukemia 2016; 30(5): 1225\u20131228","journal-title":"Leukemia"},{"issue":"1","key":"911_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41419-020-03311-1","volume":"12","author":"Z Xia","year":"2021","unstructured":"Xia Z, Zhang X, Liu P, Zhang R, Huang Z, Li D, Xiao X, Wu M, Ning N, Zhang Q, Zhang J, Liu M, Jiao B, Ren R. GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner. Cell Death Dis 2021; 12(1): 54","journal-title":"Cell Death Dis"},{"issue":"38","key":"911_CR34","doi-asserted-by":"publisher","first-page":"23594","DOI":"10.1074\/jbc.271.38.23594","volume":"271","author":"JA Duncan","year":"1996","unstructured":"Duncan JA, Gilman AG. Autoacylation of G protein alpha subunits. J Biol Chem 1996; 271(38): 23594\u201323600","journal-title":"J Biol Chem"},{"issue":"3","key":"911_CR35","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1042\/bj3020913","volume":"302","author":"MA Grassie","year":"1994","unstructured":"Grassie MA, McCallum JF, Guzzi F, Magee AI, Milligan G, Parenti M. The palmitoylation status of the G-protein G(o)1 alpha regulates its activity of interaction with the plasma membrane. Biochem J 1994; 302(3): 913\u2013920","journal-title":"Biochem J"},{"issue":"1","key":"911_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1165\/rcmb.2013-0085OC","volume":"50","author":"AS Sikarwar","year":"2014","unstructured":"Sikarwar AS, Hinton M, Santhosh KT, Chelikani P, Dakshinamurti S. Palmitoylation of G\u03b1q determines its association with the thromboxane receptor in hypoxic pulmonary hypertension. Am J Respir Cell Mol Biol 2014; 50(1): 135\u2013143","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"26","key":"911_CR37","doi-asserted-by":"publisher","first-page":"23945","DOI":"10.1074\/jbc.M101154200","volume":"276","author":"DS Evanko","year":"2001","unstructured":"Evanko DS, Thiyagarajan MM, Siderovski DP, Wedegaertner PB. G\u03b2\u03b3 isoforms selectively rescue plasma membrane localization and palmitoylation of mutant G\u03b1s and G\u03b1q. J Biol Chem 2001; 276(26): 23945\u201323953","journal-title":"J Biol Chem"},{"issue":"2","key":"911_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1128\/MCB.01144-08","volume":"29","author":"R Tsutsumi","year":"2009","unstructured":"Tsutsumi R, Fukata Y, Noritake J, Iwanaga T, Perez F, Fukata M. Identification of G protein alpha subunit-palmitoylating enzyme. Mol Cell Biol 2009; 29(2): 435\u2013447","journal-title":"Mol Cell Biol"},{"issue":"1","key":"911_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1158\/1535-7163.MCT-16-0419","volume":"16","author":"M Wu","year":"2017","unstructured":"Wu M, Huang J, Zhang J, Benes C, Jiao B, Ren R. N-Arachidonoyl dopamine inhibits NRAS neoplastic transformation by suppressing its plasma membrane translocation. Mol Cancer Ther 2017; 16(1): 57\u201367","journal-title":"Mol Cancer Ther"},{"issue":"20","key":"911_CR40","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1158\/0008-5472.CAN-18-0455","volume":"78","author":"N Ning","year":"2018","unstructured":"Ning N, Yu Y, Wu M, Zhang R, Zhang T, Zhu C, Huang L, Yun CH, Benes CH, Zhang J, Deng X, Chen Q, Ren R. A novel microtubule inhibitor overcomes multidrug resistance in tumors. Cancer Res 2018; 78(20): 5949\u20135957","journal-title":"Cancer Res"},{"issue":"6","key":"911_CR41","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.ymthe.2021.02.014","volume":"29","author":"F He","year":"2021","unstructured":"He F, Yu J, Yang J, Wang S, Zhuang A, Shi H, Gu X, Xu X, Chai P, Jia R. m6A RNA hypermethylation-induced BACE2 boosts intracellular calcium release and accelerates tumorigenesis of ocular melanoma. Mol Ther 2021; 29(6): 2121\u20132133","journal-title":"Mol Ther"},{"issue":"10","key":"911_CR42","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.3390\/cancers12102950","volume":"12","author":"K Slater","year":"2020","unstructured":"Slater K, Heeran AB, Garcia-Mulero S, Kalirai H, Sanz-Pamplona R, Rahman A, Al-Attar N, Helmi M, O\u2019Connell F, Bosch R, Portela A, Villanueva A, Gallagher WM, Jensen LD, Piulats JM, Coupland SE, O\u2019Sullivan J, Kennedy BN. High cysteinyl leukotriene receptor 1 expression correlates with poor survival of uveal melanoma patients and cognate antagonist drugs modulate the growth, cancer secretome, and metabolism of uveal melanoma cells. Cancers (Basel) 2020; 12(10): 2950","journal-title":"Cancers (Basel)"},{"issue":"6","key":"911_CR43","doi-asserted-by":"publisher","first-page":"eaav7504","DOI":"10.1126\/sciadv.aav7504","volume":"6","author":"S Tan","year":"2020","unstructured":"Tan S, Yang H, Xue S, Qiao J, Salarian M, Hekmatyar K, Meng Y, Mukkavilli R, Pu F, Odubade OY, Harris W, Hai Y, Yushak ML, Morales-Tirado VM, Mittal P, Sun PZ, Lawson D, Grossniklaus HE, Yang JJ. Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases. Sci Adv 2020; 6(6): eaav7504","journal-title":"Sci Adv"},{"key":"911_CR44","first-page":"T5","volume":"114","author":"MJ Jager","year":"2016","unstructured":"Jager MJ, Magner JAB, Ksander BR, Dubovy SR. Uveal melanoma cell lines: where do they come from? (An American Ophthalmological Society Thesis) Trans Am Ophthalmol Soc 2016; 114: T5","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"911_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/pcmr.12345","volume":"28","author":"X Yu","year":"2015","unstructured":"Yu X, Ambrosini G, Roszik J, Eterovic AK, Stempke-Hale K, Seftor EA, Chattopadhyay C, Grimm E, Carvajal RD, Hendrix MJ, Hodi FS, Schwartz GK, Woodman SE. Genetic analysis of the \u2018uveal melanoma\u2019 C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line. Pigment Cell Melanoma Res 2015; 28(3): 357\u2013359","journal-title":"Pigment Cell Melanoma Res"},{"issue":"4","key":"911_CR46","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1002\/jcb.27863","volume":"120","author":"Y Li","year":"2019","unstructured":"Li Y, He J, Qiu C, Shang Q, Qian G, Fan X, Ge S, Jia R. The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability. J Cell Biochem 2019; 120(4): 5766\u20135776","journal-title":"J Cell Biochem"},{"issue":"1","key":"911_CR47","doi-asserted-by":"publisher","first-page":"e29622","DOI":"10.1371\/journal.pone.0029622","volume":"7","author":"X Wu","year":"2012","unstructured":"Wu X, Zhu M, Fletcher JA, Giobbie-Hurder A, Hodi FS. The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. PLoS One 2012; 7(1): e29622","journal-title":"PLoS One"},{"key":"911_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ceb.2014.01.005","volume":"27","author":"M O\u2019Hayre","year":"2014","unstructured":"O\u2019Hayre M, Degese MS, Gutkind JS. Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr Opin Cell Biol 2014; 27: 126\u2013135","journal-title":"Curr Opin Cell Biol"},{"issue":"11","key":"911_CR49","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc3106","volume":"11","author":"Y Pylayeva-Gupta","year":"2011","unstructured":"Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D. RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer 2011; 11(11): 761\u2013774","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"911_CR50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrm.2015.11","volume":"17","author":"M Wang","year":"2016","unstructured":"Wang M, Casey PJ. Protein prenylation: unique fats make their mark on biology. Nat Rev Mol Cell Biol 2016; 17(2): 110\u2013122","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"911_CR51","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrm2084","volume":"8","author":"ME Linder","year":"2007","unstructured":"Linder ME, Deschenes RJ. Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol 2007; 8(1): 74\u201384","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"911_CR52","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ccell.2016.04.015","volume":"29","author":"JH Yoo","year":"2016","unstructured":"Yoo JH, Shi DS, Grossmann AH, Sorensen LK, Tong Z, Mleynek TM, Rogers A, Zhu W, Richards JR, Winter JM, Zhu J, Dunn C, Bajji A, Shenderovich M, Mueller AL, Woodman SE, Harbour JW, Thomas KR, Odelberg SJ, Ostanin K, Li DY. ARF6 is an actionable node that orchestrates oncogenic GNAQ signaling in uveal melanoma. Cancer Cell 2016; 29(6): 889\u2013904","journal-title":"Cancer Cell"},{"issue":"7","key":"911_CR53","doi-asserted-by":"publisher","first-page":"480","DOI":"10.18632\/oncoscience.57","volume":"1","author":"FX Yu","year":"2014","unstructured":"Yu FX, Zhang K, Guan KL. YAP as oncotarget in uveal melanoma. Oncoscience 2014; 1(7): 480\u2013481","journal-title":"Oncoscience"},{"issue":"546","key":"911_CR54","doi-asserted-by":"publisher","first-page":"eaao6852","DOI":"10.1126\/scisignal.aao6852","volume":"11","author":"MD Onken","year":"2018","unstructured":"Onken MD, Makepeace CM, Kaltenbronn KM, Kanai SM, Todd TD, Wang S, Broekelmann TJ, Rao PK, Cooper JA, Blumer KJ. Targeting nucleotide exchange to inhibit constitutively active G protein \u03b1 subunits in cancer cells. Sci Signal 2018; 11(546): eaao6852","journal-title":"Sci Signal"},{"issue":"4","key":"911_CR55","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","volume":"3","author":"H Yao","year":"2019","unstructured":"Yao H, Lan J, Li C, Shi H, Brosseau JP, Wang H, Lu H, Fang C, Zhang Y, Liang L, Zhou X, Wang C, Xue Y, Cui Y, Xu J. Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nat Biomed Eng 2019; 3(4): 306\u2013317","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"911_CR56","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3324\/haematol.2018.191916","volume":"104","author":"Y Lu","year":"2019","unstructured":"Lu Y, Yan JS, Xia L, Qin K, Yin QQ, Xu HT, Gao MQ, Qu XN, Sun YT, Chen GQ. 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia. Haematologica 2019; 104(1): 102\u2013112","journal-title":"Haematologica"},{"issue":"1","key":"911_CR57","doi-asserted-by":"publisher","first-page":"e80836","DOI":"10.1371\/journal.pone.0080836","volume":"9","author":"F N\u00e9mati","year":"2014","unstructured":"N\u00e9mati F, de Montrion C, Lang G, Kraus-Berthier L, Carita G, Sastre-Garau X, Berniard A, Vallerand D, Geneste O, de Plater L, Pierr\u00e9 A, Lockhart B, Desjardins L, Piperno-Neumann S, Depil S, Decaudin D. Targeting Bcl-2\/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts. PLoS One 2014; 9(1): e80836","journal-title":"PLoS One"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-021-0911-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11684-021-0911-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-021-0911-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T22:06:21Z","timestamp":1668895581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11684-021-0911-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1007\/s11684-021-0911-0","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"1 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yan Zhang, Baoyuan Zhang, Yongyun Li, Yuting Dai, Jiaoyang Li, Donghe Li, Zhizhou Xia, Jianming Zhang, Ping Liu, Ming Chen, Bo Jiao, and Ruibao Ren declare that they have no conflict of interests. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the <i>Helsinki Declaration<\/i> of 1975, as revised in 2000 (5).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}